Yueqiu N. Gao

No.528. Zhangheng Road
Pudong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

ABCB1 rs2032582 as a potential biomarker for predicting Scutellaria baicalensis Georgi-drug induced liver injury in humans.

ABCB1 rs2032582 as a potential biomarker for predicting Scutellaria baicalensis Georgi-drug induced liver injury in humans.

Journal: Journal of ethnopharmacology

Published: May 19, 2026

Congenital hepatic fibrosis in an adult female combined with Von Meyenburg complex and autosomal dominant polycystic kidney disease: a case report.

Congenital hepatic fibrosis in an adult female combined with Von Meyenburg complex and autosomal dominant polycystic kidney disease: a case report.

Journal: Frontiers in gastroenterology (Lausanne, Switzerland)

Published: May 09, 2026

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Journal: Frontiers in cellular and infection microbiology

Published: April 25, 2026

A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction.

A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction.

Journal: Frontiers in immunology

Published: December 25, 2025

Research trends of mitochondrial dysfunction in hepatic fibrosis: a bibliometric analysis.

Research trends of mitochondrial dysfunction in hepatic fibrosis: a bibliometric analysis.

Journal: Frontiers in physiology

Published: December 18, 2025

Gut microbiota-metabolism-immunity axis: a novel perspective of traditional Chinese medicine in hepatocellular carcinoma treatment.

Gut microbiota-metabolism-immunity axis: a novel perspective of traditional Chinese medicine in hepatocellular carcinoma treatment.

Journal: Chinese medicine

Published: December 06, 2025

Case report of pyloric obstruction caused by giant gallbladder compression with literature review.

Case report of pyloric obstruction caused by giant gallbladder compression with literature review.

Journal: Frontiers in surgery

Published: October 18, 2025

Randomised, controlled, crossover clinical trial protocol of puerarin for the treatment of metabolic-associated fatty liver disease in China.

Randomised, controlled, crossover clinical trial protocol of puerarin for the treatment of metabolic-associated fatty liver disease in China.

Journal: BMJ open

Published: September 18, 2025

The mechanisms and therapeutic potential of Atractylodes macrocephala Koidz in chronic liver disease management.

The mechanisms and therapeutic potential of Atractylodes macrocephala Koidz in chronic liver disease management.

Journal: Journal of ethnopharmacology

Published: June 10, 2025

Serum osteopontin levels predict short-term outcomes in patients with hepatitis B-related acute-on-chronic liver failure.

Serum osteopontin levels predict short-term outcomes in patients with hepatitis B-related acute-on-chronic liver failure.

Journal: Journal of virus eradication

Published: May 16, 2025

Activated hepatic stellate cell-derived exosomal miR-23a-3p promotes hepatocellular carcinogenesis by regulating DUSP5/ERK signaling.

Activated hepatic stellate cell-derived exosomal miR-23a-3p promotes hepatocellular carcinogenesis by regulating DUSP5/ERK signaling.

Journal: Journal of advanced research

Published: May 16, 2025

Huangjia Ruangan granules with entecavir for fibrosis regression in Chroinc Hepatitis B: A multicenter, randomized, double-blind, phase II trial.

Huangjia Ruangan granules with entecavir for fibrosis regression in Chroinc Hepatitis B: A multicenter, randomized, double-blind, phase II trial.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 04, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026